NCT04356781View on ClinicalTrials.gov

Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate with Ultimate Dosing

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 28, 2020

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions

Multifocal Motor Neuropathy (MMN)Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Trial Locations (1)

L9 7LJ

The Walton Centre NHS Foundation Trust, Liverpool

All Listed Sponsors

collaborator

Instituto Grifols, S.A.

INDUSTRY

lead

Walton Centre NHS Foundation Trust

OTHER

NCT04356781 - Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate with Ultimate Dosing | Biotech Hunter | Biotech Hunter